According to a new study published by the British Medical Journal, aspirin should not be taken by healthy seniors age 70 and over. This study suggests that the health benefits may outweigh the risk due to the internal bleeding and stomach ulcers.
This study comes as a serious hit to the multi-million dollar aspirin industry which recently endorsed scientific advice that all seniors over 50 years of age should take aspirin regularly whether they are unhealthy or not, with the assumption that it would fight against possible heart attacks and strokes especially in the senior population.
The new study published by the British Medical Journal claims that the risks of serious bleeding in seniors offsets any potential heart benefits for the senior population over 70 years of age.
According to Dr. Mark Nelson, a researcher from the University of Tasmania, he says that despite sound evidence for efficacy, the temptation to blindly implement low doses of aspirin treatment for the primary prevention of possible heart disease in the elderly should be avoided.
Simultaneously, the aspirin industry greeted these findings with skepticism, citing other studies that suggested daily aspirin for seniors over 50 years old is vital to good health.
There has been resurgence in aspirin usage after the recall of painkillers such as Vioxx and Bextra. Patients and doctors alike have, in many cases, moved back to the aspirin for its reliability.
On an annual basis, an amazing 35,000 metric tons of aspirin are produced and consumed. This equates to roughly 100 billion standard aspirin pills each year.